Metastatic Leiomyosarcoma Biomarker Protocol — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metastatic Leiomyosarcoma Biomarker Protocol — Stella

Recruiting

Back to Leiomyosarcoma trials

Trial locations(11 sites)

United States

Sarcoma Oncology Research Center, Santa Monica, California

University of Miami, Miami, Florida

Dana- Farber, Boston, Massachusetts

University of Michigan Cancer Center, Ann Arbor, Michigan

Mayo Clinic, Rochester, Minnesota

Key details

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

National Cancer Institute (NCI)

Enrollment target

~200 participants

Started

December 2022

Primary completion

December 2026

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov